Julie Jordan's Insider Trades & SAST Disclosures
Julie Jordan's most recent trade in Neurogene Inc was a trade of 50,300 Employee Stock Option (Right to buy) done . Disclosure was reported to the exchange on March 26, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Julie Jordan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neurogene Inc | Julie Jordan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 50,300 | 50,300 | - | - | Employee Stock Option (Right to buy) | |
| Neurogene Inc | Julie Jordan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 8,400 | 8,400 | - | 0 | Common Stock | |
| Neurogene Inc | Julie Jordan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 4,644 | 0 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 4,644 | 8,804 (0%) | 0% | 0 | Common Stock | |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 1,548 | 4,318 (0%) | 0% | 0 | Common Stock | |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 1,548 | 0 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 03 Aug 2023 | 1,308 | 7,496 (0%) | 0% | 1.4 | 1,818 | Common Stock |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 03 Aug 2023 | 436 | 3,882 (0%) | 0% | 1.4 | 606 | Common Stock |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 387 | 0 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 387 | 4,269 (0%) | 0% | 0 | Common Stock | |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 03 Aug 2023 | 109 | 4,160 (0%) | 0% | 1.4 | 152 | Common Stock |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 350 | 0 | - | - | Restricted Stock Units | |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 350 | 2,869 (0%) | 0% | 0 | Common Stock | |
| Q32 Bio Inc. | Julie Jordan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.31 per share. | 02 Aug 2023 | 99 | 2,770 (0%) | 0% | 1.3 | 130 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges